To determine whether electronic adherence monitoring with feedback and reminder alarms can improve adherence and health outcomes in childhood asthma.
This study will investigate whether adding an electronic adherence monitor to inhaled steroids, and feeding this information back to patients and families can improve adherence and outcomes in childhood asthma. The devices will also sound twice daily reminder alarms to act as direct medication prompts. This intervention will be compared to a control group in which adherence is monitored, but with no feedback or alarms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
90
Medication reminder alarms
Review of adherence data with action planning
Alarms deactivated and no feedback
Sheffield Children's NHS Foundation Trust
Sheffield, Sheffield (South Yorkshire District), United Kingdom
Change in asthma control from baseline at 3 months
Recorded as an Asthma Control Questionnaire (ACQ) score.Mean score of 0 -7, lower score indicating better asthma control.
Time frame: 3 months
Change in asthma control from baseline at 6 months
Recorded as an Asthma Control Questionnaire (ACQ) score.Mean score of 0 -7, lower score indicating better asthma control.
Time frame: 6 months
Change in asthma control from baseline at 9 months
Recorded as an Asthma Control Questionnaire (ACQ) score.Mean score of 0 -7, lower score indicating better asthma control.
Time frame: 9 months
Change in asthma control from baseline at 12 months
Recorded as an Asthma Control Questionnaire (ACQ) score.Mean score of 0 -7, lower score indicating better asthma control.
Time frame: 12 months
Asthma-related quality of life, as measured by the "Mini Paediatric Asthma Quality of Life Questionnaire" (Mini PAQLQ)
Mean score of 0-7, lower score indicating poorer asthma - related quality of life.
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.
Parents' illness perceptions as measured by the "brief illness perception questionnaire.
As measured by the "brief illness perception questionnaire. A higher score indicates a more threatening view of the illness.
Time frame: Recorded at baseline
Unplanned GP/ ED attendances for asthma
Number of unplanned visits to GP or A\&E for asthma in the previous 3 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.
Rescue beta-agonist use
Question score on the ACQ regarding recent beta agonist use.
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.
Adherence to ICS treatment
Electronic adherence rate as measured by the smartinhaler or smartturbo. Adherence rate calculated as percentage of prescribed doses actually taken. Adherence rate capped at 100% for any single day.
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.
Level of maintenance asthma therapy. Treatment level (modified BTS step) at 12 months and individual change in modified BTS step between baseline and 12 months
Dose of ICS
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.
Forced Expiratory Volume in 1 second (FEV1) - % predicted
% predicted value compared with Global Lung Initiative 2012 reference values.
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.
Medication beliefs
As measured by the "beliefs about medicines" questionnaire. A higher score indicates multiple concerns and doubts about inhaled steroids.
Time frame: Recorded at baseline
Rescue doses of oral steroids
Number of rescue doses of oral steroids required in the previous 3 months.
Time frame: Recorded at baseline, 3, 6, 9 and 12 months.